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Figure 3. Beginning with nature− evolving to bio-inspired
Cell-based biologicalisation in medicine
Cell-based medical systems begin with such biomanufacturing methods as the fermenter and 
bioreactor-based production of such pharmaceuticals as therapeutic enzymes and MAbs.  The 
success of such cell-based therapies as tisagenlecleucel, an FDA-approved CAR T-cell therapy for B-
cell lymphoma, illustrates the next step.  3D bioprinting and newer microfluidics, in e.g., replacing 
whole animal-based assays, can generate ex vivo cell-based systems that provide gains in analytical 
power as well as in environmental sustainability. Some cyber-physical cellular constructions are now 








Relationship of major fields
The relationship of the many contributing technologies in this new approach to manufacturing is 
complex. It begins with the field of genetic engineering, a classic means of bio-design that develops 
new products with the original style of genetic modification using restriction endonucleases and 
cloning – and is guided by both heuristics and our imagination. Improvements here yielded synthetic 
biology, highlighting the building of new bio-based materials, parts, and devices by including 
advanced biochemistry, digital algorithms, and in silico model guidance. 
Biofabrication in this context is a new and
little-discussed approach to bio-based raw 
material design and sourcing by understanding, 
adapting, and re-designing natural materials (5).
Biofabrication includes custom manufacturing 
techniques such as 3D bioprinting.  It is opening 
the door to more effective medical treatments 
and assays− and providing tools to help in drug 
screening and pharmaceutical development.  
The biologicalization of manufacturing adopts these
technologies, along with 4.0 methods.
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Natural → Synthetic → Biologicalised
The history of acetic acid (HOAc) manufacturing illustrates our evolution from biological, to 
synthetic, to bio-integrated (or biologicalised) manufacturing. 
The German method of production was a very early and natural means of production that 
percolated an alcoholic solution through a tower of wood shavings harboring Acetobacter. In the 
next approach, HOAc was generated synthetically, using energy-demanding processes employing 
chlorinated hydrocarbon intermediates, much energy and troublesome waste. 
Today the biologicalisation of the process, through genetic engineering and digital biomanufacturing 
techniques, is promising a more sustainable means of production. Benefits here include lower 
energy requirements, metals-free aqueous waste and the possibility of using such low-cost and 
green carbohydrate sources as organic municipal wastes and agriculture residues. 
We see here that an engineered application of first-generation biological systems (the German 
method) was too slow and inefficient; The 19th century way of chemical synthesis is energy and toxic 
material dependent; While current initiatives of melding molecular and synthetic biology with 
digital biomanufacturing promise the design of an bio-inspired, efficient and sustainable solution.
Digital biomanufacturing 
Sampath Kandala, director of digital product management and partnerships at GE Healthcare says of 
a bioreactor digital twin: “The twin is trained with the assistance of mechanistic and statistical 
models, and real-time machine learning from the bioreactors operation-- such as temperature, pH 
and mixing speed, and cell density.  It is more able to predict how the process will progress. For 
instance, you can obtain insight into cell density, product titer or glucose and lactose consumption. 
That makes it possible to detect faults in the process much earlier”.  [https://www.c2w.nl/ 
partnercontent/the-digital-future-of-bioprocessing/item 20066]. GE Healthcare already has a digital 
twin of a single-use mixer at production scale and is now developing a twin of a bioreactor for the 
improvement of drug development as well as the prediction of large-scale production events.
4D bioprinted models replace animals
Madeline Lancaster is Group Leader, MRC Laboratory of Molecular Biology. Her projects include 
work on a 4D model of brain tissue where cells spontaneously self-organized to form a structure 
resembling the human brain. These “cerebral organoids” are an in vitro replica of  the complexity 
and structure of the developing brain. These organ-like structures
can be used to model human disease. Animal models used in 
studying brain development have many  limitations, including 
the lower complexity and lack crucial components in the brains 
of rats and mice. Cerebral organoids are valuable in not only 
studying mechanisms and treatments of neurological disease 
but also in completely replacing some animal studies [Figure 3]. 
Dr. Lancaster was winner of LMB’s Cell Biology  Division 3Rs Prize, 
which had been sponsored by GlaxoSmithKline (GSK) [6].
Advantages over live animals or their tissues begin with their economy, efficiency and modifiability.   
They are also more controllable, amenable to multiplex monitoring and, finally, are more humane.  
We refer to such cell-based systems as “biologicalised”, due of the human engineering required.
Introduction
The biological transformation of manufacturing begins with the incorporation of bio-inspired 
systems materials, chemistries, and catalysts.  This can be supported by structures, enzymes, 
metabolisms and cells.  It continues with bio-integrated process design – from equipment and 
assemblies to resources, processes, and facilities. Finally, it develops bio-intelligent systems and 
supply chains feeding a global, circular economy [Figure 1]. Biologicalisation is another term used 
for this use of excerpted biological pathways, as well a entire plants, bacteria and animal cells.
As much as biology, it is based upon Industry 4.0 tools, algorithms and methods.  This includes 
advanced computer hardware and software; industrial internet of things (IIoT); advanced data 
handling and automation; artificial intelligence; predictive modeling and machine learning (4).
Industry 4.0 goals specifically include sustainable enterprise manufacturing. They apply to systems 
in product design and development, process analytics and manufacturing– as well as to post-
commercialization surveillance (4).  So, bologicalisation is more than only cellular systems or 
biomimetic chemistries. It includes application of such modern digital techniques as advanced 
process monitoring, the IIoT, Cloud applications, AI and model reference adaptive control.
Abstract
Industry 4.0 is changing manufacturing concepts (1). Biologicalisation uses 4.0 principles in concert 
with biological and bio-inspired materials, chemistries and functions to support efficient and 
sustainable manufacturing. From product design to development and production, biomimetic 
product implementations and bio-integrated manufacturing systems embody this biological 
transformation of manufacturing (2).  This process applies to both manufacturing and medicine.
Processes, chemistries and supply chains are being enhanced by the harmonization of newer digital 
manufacturing principals and applications, and advanced process understandings, with biological 
systems and materials. This is enabling streamlined product designs and  providing efficient, clean 
and robust production that better supports sustainable, circular and global economies.
Progress in our understanding of biological elements, phenomena, substrates and chemistries 
enables this revolution. In fact, a 2018 Nobel Prize winner in Chemistry year, Frances H. Arnold 
illustrates this. She invented systems directing the engineering of enzymes now routinely used in 
development of such tools as catalysts in manufacturing [Figure 1]. This technology supports the 
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Biomimetic-structure based biologicalisation
Lipitor is a success story of small-molecule biologicalisation.  Pfizer had previously improved Lipitor 
manufacturing in ways that reduced organic waist by 65% [7].  Yet, the remaining 35% remained an 
issue.  For example, the methanol and tetrahydrofuran in the process is a problem in disposal 
R. Heck, E. Negishi, A. Suzuki took the 2010 Nobel Prize in Chemistry for Palladium-based carbon 
couplings in aqueous solutions.  Reactions can occur at room temperature and in water/acetonitrile 
and water/toluene biphasic mixtures-- or even in neat water.
Bruce Lipshutz (UCSB) has a further improvement that uses a self-assembling surfactant in an 
aqueous medium [8].  The micelles produced mimic a living cell in sequestering reactions and 
components from the general environment. This system can support many common reactions, 
including carbon cross–couplings at room temperature.  Such structured reactions require only parts 
per million transition metals in an organic solvent-reduced / -free environment [Figure 4].
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Figure 4. Biologicalisation of carbon couplings
Evolution of cell-based medical biologicalisation
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